INDUSTRY SESSIONS

WEDNESDAY, 15 October 2025

The Devil Wears GP120: CD4 counts!

 

Company: Virology Education
Room: Amphithéâtre Bleu
Date: 15 October 2025
Time: 11:30 – 12:30
Session title: The Devil Wears GP120: CD4 counts!
Speakers:
– Georg Behrens (Germany), Chair
– Georg Behrens (Germany)
– Chloe Orkin (UK)
– Andrés Finzi (Canada)

This symposium is supported by an independent medical education grant by ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

A Long Shot Becomes Reality: Be Part of History

 

Company: Gilead Sciences, Inc.
Room: Amphithéâtre Bleu
Date: 15 October 2025
Time: 13:00 – 14:00
Session title: A Long Shot Becomes Reality: Be Part of History
Speakers:
– Chloe Orkin (UK), Chair
– Pablo Ryan (Spain)
– Chloe Orkin (UK)
– Chloe Orkin (UK)
– Onyema Ogbuagu (US)
– Jade Ghosn (France)

Her life: A different journey to long-term success?

 

Company: Gilead Sciences, Inc.
Room: Amphithéâtre Bleu
Date: 15 October 2025
Time: 15:00 – 16:00
Session title: Her life: A different journey to long-term success?
Session description: Experience from clinical trials and real-world data across broad populations of people with HIV are essential to ensure comprehensive understanding of the effects of ART and to support informed treatment selection. There are existing gaps in care and research representation for some underserved populations, including women across their lifespan. In this discussion-oriented, educational and scientific session, a panel of scientific / clinical experts will discuss considerations for HIV treatment across women’s life stages – adolescence / young women, adult women, and older women. The conversation will centre around community testimony, via pre-recorded video(s), that gives voice to the concerns that women with HIV face, faculty discussion of key data that inform management decisions and audience engagement.
Speakers:
– Giulia Marchetti (Italy), Chair
– Giulia Marchetti (Italy)
– Shema Tariq (UK)
– Laurence Slama (France)

THURSDAY, 16 October 2025

The Long-acting Debate: Are We Equipped to End the Epidemic?

 

Company: ViiV Healthcare
Room: Amphithéâtre Bleu
Date: 16 October 2025
Time: 08:00 – 09:00
Session title: The Long-acting Debate: Are We Equipped to End the Epidemic?
Speakers:
– Samia Dakhia (UK), Chair
– Karine Lacombe (France)
– Christoph Spinner (Germany)
– Jonathan Schapiro (Israel)
– Karine Lacombe (France)

Session Description: Where better to kick start your EACS experience than at the ViiV Healthcare Debate Symposium? Join Prof. Jonathan Schapiro and Prof. Christoph Spinner as they go head-to-head in a dynamic debate on the challenges and possible solutions for ending the HIV epidemic. With Prof. Karine Lacombe and Dr Samia Dakhia moderating a live Q&A, it is sure to be a lively discussion. What will be the outcome of the debate? Come and find out. Don’t forget to vote in our poll!
These events are ViiV Healthcare-sponsored symposia for Healthcare Professionals only. © 2025 ViiV Healthcare SAS or its licensors. All rights reserved.
NX-GBL-HVX-ADVR-250005, Oct 2025

The Long-acting Discussion: Linking Evidence, Clinical Cases and Care

 

Company: ViiV Healthcare
Room: Amphithéâtre Bleu
Date: 16 October 2025
Time: 12:30 – 14:00
Session title: The Long-acting Discussion: Linking Evidence, Clinical Cases and Care
Speakers:
– Karine Lacombe (France), Chair
– Jade Ghosn (France)
– Maria de Lagarde* (Spain), *video only
– Monica Gandhi (United States)
– Antoine Faycal* (France), *video only
– Chloe Orkin (UK)
– Kirsty Abu-Rajab* (UK), *video only

Session Description: Join us in a real-world, case-based discussion! Our expert panel, Prof. Jade Ghosn, Prof. Monica Gandhi and Prof. Chloe Orkin, will break down challenging clinical cases presented by Dr Maria de Lagarde, Dr Antoine Faycal and Dr Kirsty Abu-Rajab. They will draw on their expertise to explore how evidence-based medicine can support clinical practice. The session will then conclude with a panel discussion and live Q&A moderated by Prof. Karine Lacombe. Ahead of the session, how confident are you in managing your patients using long-acting options? Don’t forget to vote in our poll!
These events are ViiV Healthcare-sponsored symposia for Healthcare Professionals only. © 2025 ViiV Healthcare SAS or its licensors. All rights reserved.
NX-GBL-HVX-ADVR-250005, Oct 2025

Ending the epidemic in Europe: Policy challenges and opportunities

 

Company: MSD
Room: Amphithéâtre Bleu
Date: 16 October 2025
Time: 16:15 – 17:15
Session title: Ending the epidemic in Europe: Policy challenges and opportunities
Speakers:
– Esteban Martínez (Spain), Chair
– Esteban Martínez (Spain)
– Mariana Mărdărescu (Romania)
– Jürgen Rockstroh (Germany)

Session Description: Despite significant progress on HIV in Europe, notable challenges remain. This policy symposium aims to explore challenges in Spain, Romania, and Germany and make recommendations for policy reforms needed at both the national and EU level. Further, as the epidemic evolves, new challenges such as HIV & Aging are emerging. Policy action is needed to tackle these challenges.

At the end of this session, audience members will be able to:

  • Describe the challenges to ending the HIV epidemic in Spain, Romania, and Germany
  • Identify national and EU-level policies needed to end the epidemic in Europe

FRIDAY, 17 October 2025

What’s preventing us from HIV prevention? Leaving no person behind

 

Company: Gilead Sciences, Inc.
Room: Amphithéâtre Bleu
Date: 17 October 2025
Time: 08:00 – 09:00
Session title: What’s preventing us from HIV prevention? Leaving no person behind
Session description: The HIV landscape continues to evolve across Europe, and our attention is brought to historically underserved populations in greater need of improved access to HIV prevention services. During this Gilead-sponsored symposium at EACS 2025, a multidisciplinary panel of infectious disease specialists and community representatives will discuss the unmet HIV prevention needs of migrants, women, and other key populations. Barriers to biomedical, behavioural, and structural interventions will be illustrated, and learnings will be shared from successful initiatives helping to connect individuals who need or want HIV prevention to services they can benefit from. The time to act is now: we cannot leave anyone behind in our mission to end new HIV transmissions in Europe

Speakers:
– Susan Cole-Haley (UK), Chair
– Karine Lacombe (France)
– Rosaline M’Bayo (Germany)
– Vanessa Apea (UK)
– Karine Lacombe (France)
– Vanessa Apea (UK)

Optimization of HIV care

 

Company: MSD
Room: Amphithéâtre Bleu
Date: 17 October 2025
Time: 12:30 – 14:00
Session title: Optimization of HIV care
Speakers:
– Karine Lacombe (France), Chair
– Paddy Mallon (Ireland)
– Jonathan Schapiro (Israel)
– Jürgen Rockstroh (Germany)

Key learning objectives for this program include:

  • Considerations around the practical identification and management of cardiometabolic comorbidities and weight gain in PLWH, especially as it relates to ART choice or change.
  • Identification and management of HIV resistance, especially in the setting of current standard of care and upcoming ART regimens.
  • Management of older adult PLWH, including polypharmacy and DDIs.

EACS 2025 Chatbot